As Kentucky gets closer to authorizing optometrists to perform certain eye surgeries, the actual scope of their new privileges was outlined by a legislative committee that recently allowed the authorization to proceed, according to a Glasgow Daily Times report.
Uncategorized
Several members of the Senate Health, Education, Labor and Pensions Committee called for tightening a 1938 law so that the FDA could improve the safety of imported drugs, according to a Star-Ledger report.
As authorities clamp down on abuse of prescription painkillers and similar substances, more physicians are receiving criminal charges for involvement in fatal overdoses of patients, according to a Reuters report.
Shawn Lunney is vice president of sales and marketing for GMD in Gig Harbor, Wash., which develops generic medical devices.
Pleading guilty to misbranding one of its heart drugs, Johnson & Johnson’s Scios unit has agreed to pay an $85 million fine, according to a Bloomberg report. Scios was charged in July with misbranding its drug, Natrecor, one of the…
Advertisement
The New Jersey Association of Ambulatory Surgery Centers has initiated a letter writing campaign to request changes to Proposal 163, the new personal injury protection regulations proposed by the New Jersey Department of Banking and Insurance (DOBI), according to Jeffrey…
Ansell Limited, a provider of protection solutions, has announced it has been recognized for the company's contribution through the Power of PINK Program to Susan G. Komen for the Cure in a personal letter from Komen Founder and CEO Nancy…
8 Problem Areas for ASCs in a Medicare Survey John J. Goehle, COO of Ambulatory Healthcare Strategies in Rochester and Albany, N.Y., is author of “The Survey Guide for ASCs – A Guide to the CMS Conditions for Coverage &…
HHS has closed the public's limited access to its National Practitioner Data Bank, which houses information about healthcare providers such as disciplinary action, according to a Kansas City Star report.
In a trial of nearly 3,000 participants, researchers found 25 percent of participants mistakenly believed the FDA approves only drugs without serious side effects, and more than one-third mistakenly believed that the FDA approves only “extremely effective” drugs, according to…